Minnesota HIE: a work in progress.

Healthc Inform

Published: February 2014

Download full-text PDF

Source

Publication Analysis

Top Keywords

minnesota hie
4
hie work
4
work progress
4
minnesota
1
work
1
progress
1

Similar Publications

Article Synopsis
  • Infants with hypoxic ischemic encephalopathy (HIE) may have underlying genetic or congenital anomalies, which could influence their health outcomes, but the extent of this impact is not well understood.
  • In a study of 500 infants with HIE, 5% were found to have genetic or congenital anomalies; these infants showed higher rates of death or neurodevelopmental impairment (NDI) compared to those without anomalies.
  • Despite similar severity of HIE, infants with genetic or congenital issues had worse neurological outcomes, including higher instances of cerebral palsy and lower developmental scores at age two.
View Article and Find Full Text PDF

Background: The epidemiology of coronavirus disease 2019 (COVID-19) continues to develop with emerging variants, expanding population-level immunity, and advances in clinical care. We describe changes in the clinical epidemiology of COVID-19 hospitalizations and risk factors for critical outcomes over time.

Methods: We included adults aged ≥18 years from 10 states hospitalized with COVID-19 June 2021-March 2023.

View Article and Find Full Text PDF

Hypoxic ischemic encephalopathy (HIE) remains a significant cause of disability despite treatment with therapeutic hypothermia (TH). Many survive with more subtle deficits that affect daily functioning and school performance. We have previously shown an early indication of hippocampal changes in infants with HIE despite TH.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to evaluate the effectiveness of COVID-19 booster doses in preventing hospitalizations and emergency department visits, providing insight for public health policies.
  • Data was collected from over 1.2 million adults at five health systems during the Omicron variant's rise, showing that approximately 37% received a booster dose.
  • The median number needed to vaccinate (NNV) to prevent one hospitalization was 205, with lower NNV for adults aged 65 and older and those with health conditions, indicating booster effectiveness varies by age and health status.
View Article and Find Full Text PDF

Background: Coronavirus disease 2019 (COVID-19) vaccination coverage remains lower in communities with higher social vulnerability. Factors such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure risk and access to healthcare are often correlated with social vulnerability and may therefore contribute to a relationship between vulnerability and observed vaccine effectiveness (VE). Understanding whether these factors impact VE could contribute to our understanding of real-world VE.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!